» Articles » PMID: 34578877

Comparison of the Impact of Xanthohumol and Phenethyl Isothiocyanate and Their Combination on Nrf2 and NF-κB Pathways in HepG2 Cells In Vitro and Tumor Burden In Vivo

Overview
Journal Nutrients
Date 2021 Sep 28
PMID 34578877
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

: Increasing evidence suggests that combinations of phytochemicals are more efficient than single components in the modulation of signaling pathways involved in cancer development. In this study, the impact of phenethyl isothiocyanate (PEITC), indole-3-carbinol (I3C), xanthohumol, (X), and resveratrol (RES) and their combinations on the activation and expression of Nrf2 and NF-κB in human hepatocytes and HCC cells were evaluated. : THLE-2 and HepG2 cells were exposed to single phytochemicals and their combinations for 24 h. The activation of Nrf2 and NF-κB, expression of their target genes, and effect on cells survival were assessed. The tumor burden was evaluated in mice carrying xenografts. : All phytochemicals enhanced the activation and expression of Nrf2 and its target genes and in HepG2 cells. The increased expression of (~90%) was associated with increased ROS generation. X + PEITC downregulated NF-κB activation reducing binding of its active subunits to DNA resulting in diminished expression. In contrast to single phytochemicals, X + PEITC induced apoptosis. Moderate reduction of tumor burden in mice carrying xenografts following X and PEITC or their combination was observed. : Since Nrf2 is overexpressed in HCC its reduced activation together with diminished level of NF-κB by X + PEITC may be considered as a strategy to support conventional HCC therapy.

Citing Articles

Modulatory Effects of Chalcone Thio-Derivatives on NF-κB and STAT3 Signaling Pathways in Hepatocellular Carcinoma Cells: A Study on Selected Active Compounds.

Papierska K, Judasz E, Toninska W, Kubicki M, Krajka-Kuzniak V Int J Mol Sci. 2024; 25(19).

PMID: 39409068 PMC: 11476945. DOI: 10.3390/ijms251910739.


The Aryl Hydrocarbon Receptor and Its Crosstalk: A Chemopreventive Target of Naturally Occurring and Modified Phytochemicals.

Szaefer H, Licznerska B, Baer-Dubowska W Molecules. 2024; 29(18).

PMID: 39339278 PMC: 11433792. DOI: 10.3390/molecules29184283.


Evening Primrose Extract Modulates TYMS Expression via SP1 Transcription Factor in Malignant Pleural Mesothelioma.

Chmielewska-Kassassir M, Sobierajska K, Ciszewski W, Kryczka J, Zieleniak A, Wozniak L Cancers (Basel). 2023; 15(20).

PMID: 37894370 PMC: 10605291. DOI: 10.3390/cancers15205003.


Antitumor Effects of Dietary Compounds.

Bhutta Z, Choi K Nutrients. 2023; 15(10).

PMID: 37242231 PMC: 10222962. DOI: 10.3390/nu15102349.


Nutri-PEITC Jelly Significantly Improves Progression-Free Survival and Quality of Life in Patients with Advanced Oral and Oropharyngeal Cancer: A Blinded Randomized Placebo-Controlled Trial.

Lam-Ubol A, Sukhaboon J, Rasio W, Tupwongse P, Tangshewinsirikul T, Trachootham D Int J Mol Sci. 2023; 24(9).

PMID: 37175527 PMC: 10177844. DOI: 10.3390/ijms24097824.


References
1.
Zhang D, Hannink M . Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol Cell Biol. 2003; 23(22):8137-51. PMC: 262403. DOI: 10.1128/MCB.23.22.8137-8151.2003. View

2.
Saito K, Matsuo Y, Imafuji H, Okubo T, Maeda Y, Sato T . Xanthohumol inhibits angiogenesis by suppressing nuclear factor-κB activation in pancreatic cancer. Cancer Sci. 2017; 109(1):132-140. PMC: 5765302. DOI: 10.1111/cas.13441. View

3.
Krajka-Kuzniak V, Paluszczak J, Baer-Dubowska W . Xanthohumol induces phase II enzymes via Nrf2 in human hepatocytes in vitro. Toxicol In Vitro. 2012; 27(1):149-56. DOI: 10.1016/j.tiv.2012.10.008. View

4.
Vazquez Loureiro P, Hernandez Jimenez I, Sendon R, Quiros A, Barbosa-Pereira L . Determination of Xanthohumol in Hops, Food Supplements and Beers by HPLC. Foods. 2019; 8(10). PMC: 6835515. DOI: 10.3390/foods8100435. View

5.
Dodson M, Zhang D . Non-canonical activation of NRF2: New insights and its relevance to disease. Curr Pathobiol Rep. 2017; 5(2):171-176. PMC: 5654572. DOI: 10.1007/s40139-017-0131-0. View